Quantitative Systematic Strategies’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-14,623
Closed -$163K 563
2021
Q1
$163K Buy
+14,623
New +$154K 0.03% 577
2020
Q3
Sell
-23,359
Closed -$241K 653
2020
Q2
$241K Buy
+23,359
New +$239K 0.05% 469
2018
Q2
Sell
-13,903
Closed -$180K 689
2018
Q1
$180K Buy
+13,903
New +$173K 0.04% 573
2017
Q1
Sell
-59,402
Closed -$758K 391
2016
Q4
$758K Sell
59,402
-32,252
-35% -$407K 0.31% 146
2016
Q3
$1.19M Buy
91,654
+21,565
+31% +$252K 0.44% 77
2016
Q2
$761K Buy
70,089
+52,238
+293% +$510K 0.36% 133
2016
Q1
$157K Sell
17,851
-52,847
-75% -$436K 0.06% 278
2015
Q4
$701K Buy
70,698
+24,863
+54% +$240K 0.19% 128
2015
Q3
$400K Sell
45,835
-58,903
-56% -$550K 0.2% 211
2015
Q2
$1.02M Buy
+104,738
New +$1.22M 0.23% 151
2015
Q1
Sell
-15,936
Closed -$203K 456
2014
Q4
$203K Buy
+15,936
New +$182K 0.08% 285

Other funds holding IRWD

Quantitative Systematic Strategies's IRWD Position: Q2 2021 in Review

Quantitative Systematic Strategies sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2021, closing a stake of 14,623 shares — an estimated $163K sold.

Quantitative Systematic Strategies first reported a position in IRWD in Q4 2014 and held it in 11 quarters. The position peaked at $1.19M in Q3 2016. 208 funds tracked by Wall St. Rank hold IRWD as of Q2 2021.

  • Quantitative Systematic Strategies reported no remaining Ironwood Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 14,623 Ironwood Pharmaceuticals shares in Q2 2021, an estimated $163K.
  • Quantitative Systematic Strategies first reported a position in Ironwood Pharmaceuticals in Q4 2014 and held it in 11 quarters.
  • Quantitative Systematic Strategies's Ironwood Pharmaceuticals position peaked at $1.19M in Q3 2016.
  • 208 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2021, filed 5 Aug 2021.